Related references
Note: Only part of the references are listed.Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcoma
N. Rainusso et al.
CANCER GENE THERAPY (2012)
Anti-EGFR Antibody Cetuximab Enhances the Cytolytic Activity of Natural Killer Cells toward Osteosarcoma
Jens H. W. Pahl et al.
CLINICAL CANCER RESEARCH (2012)
Sensitization of human osteosarcoma cells to Vγ9Vδ2 T-cell-mediated cytotoxicity by zoledronate
Zhaoxu Li et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2012)
Body-barrier surveillance by epidermal γδ TCRs
Grzegorz Chodaczek et al.
NATURE IMMUNOLOGY (2012)
The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols
D. Andreou et al.
ANNALS OF ONCOLOGY (2011)
γδ T cell Receptor Ligands and Modes of Antigen Recognition
Eric Champagne
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2011)
Bisphosphonates: The first 40 years
R. Graham G. Russell
BONE (2011)
Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
A. J. Nicol et al.
BRITISH JOURNAL OF CANCER (2011)
Addition of Pamidronate to Chemotherapy for the Treatment of Osteosarcoma
Paul A. Meyers et al.
CANCER (2011)
Elevated Expression of CXC Chemokines in Pediatric Osteosarcoma Patients
Yiting Li et al.
CANCER (2011)
Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma
Hirohito Kobayashi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells
Emilie P. Buddingh et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma
Joshua M. Lang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
High Phosphoantigen Levels in Bisphosphonate-Treated Human Breast Tumors Promote Vγ9Vδ2 T-Cell Chemotaxis and Cytotoxicity In Vivo
Ismahene Benzaid et al.
CANCER RESEARCH (2011)
γδ T-cells: cross-talk between innate and adaptive immunity
Dieter Kabelitz
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Searching for signal 2: costimulation requirements of γδ T cells
Julie C. Ribot et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Tumor-associated-antigens or osteosarcoma cell line lysates: Two efficient methods for in vitro generation of CTLs with special regard to MHC-I restriction
Michela Muraro et al.
CELLULAR IMMUNOLOGY (2011)
CD70-CD27 interactions provide survival and proliferative signals that regulate T cell receptor-driven activation of human gamma delta peripheral blood lymphocytes
Ana deBarros et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Mifamurtide for the treatment of nonmetastatic osteosarcoma
Kosei Ando et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
γδ T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody
Mounia Sabrina Braza et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
IFN-γ enhances HOS and U2OS cell lines susceptibility to γδ T cell-mediated killing through the Fas/Fas ligand pathway
Zhaoxu Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Immune Modulation by Zoledronic Acid in Human Myeloma: An Advantageous Cross-Talk between Vγ9Vδ2 T Cells, αβ CD8+ T Cells, Regulatory T Cells, and Dendritic Cells
Barbara Castella et al.
JOURNAL OF IMMUNOLOGY (2011)
Stimulated γδ T Cells Increase the In Vivo Efficacy of Trastuzumab in HER-2+ Breast Cancer
Aude-Helene Capietto et al.
JOURNAL OF IMMUNOLOGY (2011)
Adoptive Immunotherapy for Advanced Non-small Cell Lung Cancer Using Zoledronate-expanded γδ T Cells: A Phase I Clinical Study
Miki Sakamoto et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Preclinical evaluation of ex vivo expanded/activated gamma delta T cells for immunotherapy of glioblastoma multiforme
Nichole L. Bryant et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8+ T-lymphocyte infiltration and affect tumour progression
Dagmar Berghuis et al.
JOURNAL OF PATHOLOGY (2011)
Prognostic Significance of HLA Class I Expression in Ewing's Sarcoma Family of Tumors
Hiroki Yabe et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Anti-Leukemia Activity of In Vitro-Expanded Human Gamma Delta T Cells in a Xenogeneic Ph+ Leukemia Model
Gabrielle M. Siegers et al.
PLOS ONE (2011)
Survival in high-grade osteosarcoma: improvement over 21 years at a single institution
P. Picci et al.
ANNALS OF ONCOLOGY (2010)
Human γδ T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement
Amudhan Maniar et al.
BLOOD (2010)
The epidemiology of bone cancer in 0-39 year olds in northern England, 1981-2002
Rachel Eyre et al.
BMC CANCER (2010)
Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vγ9Vδ2 T lymphocyte agonist in patients with solid tumors
Jaafar Bennouna et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Targeting γδ T Lymphocytes for Cancer Immunotherapy: From Novel Mechanistic Insight to Clinical Application
Anita Q. Gomes et al.
CANCER RESEARCH (2010)
Cytotoxicity of Activated Natural Killer Cells against Pediatric Solid Tumors
Duck Cho et al.
CLINICAL CANCER RESEARCH (2010)
A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous γδ T cells
Jun Nakajima et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2010)
γδ T lymphocytes kill T regulatory cells through CD1d
Sally A. Huber
IMMUNOLOGY (2010)
NKG2D Costimulates Human Vγ9Vδ2 T Cell Antitumor Cytotoxicity through Protein Kinase Cθ-Dependent Modulation of Early TCR-Induced Calcium and Transduction Signals
Steven Nedellec et al.
JOURNAL OF IMMUNOLOGY (2010)
Vγ9Vγ2 T Lymphocytes Efficiently Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and Imatinib-Resistant Chronic Myelogenous Leukemia Cells
Matilde D'Asaro et al.
JOURNAL OF IMMUNOLOGY (2010)
V gamma 2V delta 2 T Cell Receptor Recognition of Prenyl Pyrophosphates Is Dependent on All CDRs
Hong Wang et al.
JOURNAL OF IMMUNOLOGY (2010)
Arsenic trioxide inhibits the growth of Adriamycin resistant osteosarcoma cells through inducing apoptosis
Hui Zhao et al.
MOLECULAR BIOLOGY REPORTS (2010)
Prognostic Significance of Early Lymphocyte Recovery in Pediatric Osteosarcoma
Colin Moore et al.
PEDIATRIC BLOOD & CANCER (2010)
The Junctional Adhesion Molecule JAML Is a Costimulatory Receptor for Epithelial γδ T Cell Activation
Deborah A. Witherden et al.
SCIENCE (2010)
γδ T cell effector functions: a blend of innate programming and acquired plasticity
Marc Bonneville et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Adoptive immunotherapy of lung cancer with immobilized anti-TCRγδ antibody-expanded human γδ T-cells in peripheral blood
Ning Kang et al.
CANCER BIOLOGY & THERAPY (2009)
Immune approaches to treating osteosarcoma
Neyssa Marina et al.
CANCER BIOLOGY & THERAPY (2009)
TCR transgenes and transgene cassettes for TCR gene therapy: status in 2008
Wolfgang Uckert et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Adoptive cell therapy for the treatment of patients with metastatic melanoma
Steven A. Rosenberg et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Rapid αβ TCR-mediated responses in γδ T cells transduced with cancer-specific TCR genes
A. Hiasa et al.
GENE THERAPY (2009)
Pitfalls on the roadmap to γδ T cell-based cancer immunotherapies
Ludovic Martinet et al.
IMMUNOLOGY LETTERS (2009)
Expression of intercellular adhesion molecule (ICAM)-1 or ICAM-2 is critical in determining sensitivity of pancreatic cancer cells to cytolysis by human γδ-T cells: Implications in the design of γδ-T-cell-based immunotherapies for pancreatic cancer
Zhiyong Liu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
alpha beta T Cell Receptor Transfer to gamma delta T Cells Generates Functional Effector Cells without Mixed TCR Dimers In Vivo
Lars T. van der Veken et al.
JOURNAL OF IMMUNOLOGY (2009)
Efficient Killing of Human Colon Cancer Stem Cells by gamma delta T Lymphocytes
Matilde Todaro et al.
JOURNAL OF IMMUNOLOGY (2009)
The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression
Pratip K. Chattopadhyay et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Osteosarcoma
Patrick J. Messerschmitt et al.
JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS (2009)
Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression
Nabil Ahmed et al.
MOLECULAR THERAPY (2009)
Cross-presenting human γδ T cells induce robust CD8+ αβ T cell responses
Marlene Brandes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A Rapid Crosstalk of Human γδ T Cells and Monocytes Drives the Acute Inflammation in Bacterial Infections
Matthias Eberl et al.
PLOS PATHOGENS (2009)
Engineering lymphocyte subsets: tools, trials and tribulations
Carl H. June et al.
NATURE REVIEWS IMMUNOLOGY (2009)
State-of-the-art approach in selective curable tumors: bone sarcoma
S. S. Bielack et al.
ANNALS OF ONCOLOGY (2008)
Poor prognosis osteosarcoma: new therapeutic approach
F. Fagioli et al.
BONE MARROW TRANSPLANTATION (2008)
Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
Jaafar Bennouna et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
The plasticity of γδ T cells:: Innate immunity, antigen presentation and new immunotherapy
Rita Casetti et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2008)
Isopentenyl pyrophosphate-activated CD516+ γδ T lymphocytes display potent antitumor activity toward human squamous cell carcinoma
Alan A. Z. Alexander et al.
CLINICAL CANCER RESEARCH (2008)
Liposomal muramyl tripeptide phosphatidyl ethanolamine: a safe and effective agent against osteosarcoma pulmonary metastases
Kanji Mori et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2008)
Long-term phenotypic, functional and genetic stability of cancer-specific T-cell receptor (TCR) αβ genes transduced to CD8+ T cells
A. Hiasa et al.
GENE THERAPY (2008)
Long-term functionality of TCR-transduced T cells in vivo
Miriam Coccoris et al.
JOURNAL OF IMMUNOLOGY (2008)
NF-κB Modulates Sensitivity to Apoptosis, Proinflammatory and Migratory Potential in Short- versus Long-Term Cultured Human γδ Lymphocytes
Marina Ferrarini et al.
JOURNAL OF IMMUNOLOGY (2008)
Anti-tumor cytotoxicity of γδ T cells expanded from peripheral blood cells of patients with myeloma and lymphoma
Anri Saitoh et al.
MEDICAL ONCOLOGY (2008)
V gamma 9V delta 2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas
Francoise Bouet-Toussaint et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Steven A. Rosenberg et al.
NATURE REVIEWS CANCER (2008)
Osteosarcoma cell line growth inhibition by zoledronate-stimulated effector cells
M. Muraro et al.
CELLULAR IMMUNOLOGY (2007)
In vitro expansion of gamma delta T cells with anti-myeloma cell activity by Phosphostim and IL-2 in patients with multiple myeloma
Maka Burjanadze et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Targeting human γδ T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer
Francesco Dieli et al.
CANCER RESEARCH (2007)
Immune reconstitution prevents metastatic recurrence of murine osteosarcoma
Melinda S. Merchant et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study
Hirohito Kobayashi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Prognostic significance of HLA class I expression in osteosarcoma defined by anti-pan HLA class I monoclonal antibody, EMR8-5
Tomohide Tsukahara et al.
CANCER SCIENCE (2006)
Human Vγ9Vδ2 T cells:: promising new leads for immunotherapy of infections and tumors
Marc Bonneville et al.
CURRENT OPINION IN IMMUNOLOGY (2006)
αβ T-cell receptor engineered γδ T cells mediate effective antileukemic reactivity
LT van der Veken et al.
CANCER RESEARCH (2006)
Adoptive T cell therapy of solid cancers
KL Knutson et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma-bearing mice
B Ory et al.
CANCER (2005)
Combination immunotherapy with clinical-scale enriched human γδ T cells, hu14.18 antibody, and the immunocytokine Fc-IL7 in disseminated neuroblastoma
M Otto et al.
CLINICAL CANCER RESEARCH (2005)
Vγ9Vδ2 T cell response to colon carcinoma cells
M Corvaisier et al.
JOURNAL OF IMMUNOLOGY (2005)
Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors:: use as a possible therapeutic approach of osteosarcoma -: art. no. 123
S Théoleyre et al.
BMC CANCER (2005)
Innate anti-breast cancer immunity of apoptosis-resistant human γδ-T cells
BL Guo et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Professional antigen-presentation function by human γδ T cells
M Brandes et al.
SCIENCE (2005)
Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma
D Heymann et al.
BONE (2005)
Ex vivo expanded human Vγ9Vδ2+γδ-T cells mediate innate antitumor activity against human prostate cancer cells in vitro
ZY Liu et al.
JOURNAL OF UROLOGY (2005)
γδ T cells:: A new frontier for immunotherapy?
LS Lamb et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Tumor recognition following V gamma 9V delta 2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I
E Scotet et al.
IMMUNITY (2005)
Effect of human natural killer and gamma delta T cells on the growth of human autologous melanoma xenografts in SCID mice
F Lozupone et al.
CANCER RESEARCH (2004)
The Fas/Fas ligand pathway is important for optimal tumor regression in a mouse model of CTL adoptive immunotherapy of experimental CMS4 lung metastases
SA Caldwell et al.
JOURNAL OF IMMUNOLOGY (2003)
Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells
HJ Gober et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Targeting of tumor cells for human γδ T cells by nonpeptide antigens
Y Kato et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
